Header Logo

Connection

MICHAEL ITTMANN to MicroRNAs

Back to Details
This is a "connection" page, showing publications MICHAEL ITTMANN has written about MicroRNAs.
MICHAEL ITTMANN
Connection Strength
0.976
MicroRNAs
  1. Overexpression of miR-145-5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression. Cancer Invest. 2015 Jul; 33(6):251-8.
    View in: PubMed
    Score: 0.201
  2. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene. 2008 Mar 13; 27(12):1788-93.
    View in: PubMed
    Score: 0.118
  3. CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis. Prostate Cancer Prostatic Dis. 2021 09; 24(3):891-902.
    View in: PubMed
    Score: 0.075
  4. MicroRNAs as prognostic markers in prostate cancer. Prostate. 2019 02; 79(3):265-271.
    View in: PubMed
    Score: 0.064
  5. Identification of microRNA profile specific to cancer stem-like cells directly isolated from human larynx cancer specimens. BMC Cancer. 2016 11 05; 16(1):853.
    View in: PubMed
    Score: 0.056
  6. The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors. Oncotarget. 2016 Jun 21; 7(25):37993-38003.
    View in: PubMed
    Score: 0.054
  7. Dysregulation of miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to the metastasis of prostate cancer. Nat Commun. 2016 04 25; 7:11418.
    View in: PubMed
    Score: 0.054
  8. The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells. Tumour Biol. 2016 Mar; 37(3):4183-92.
    View in: PubMed
    Score: 0.052
  9. Role of miR-145 in human laryngeal squamous cell carcinoma. Head Neck. 2016 Feb; 38(2):260-6.
    View in: PubMed
    Score: 0.051
  10. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer. Int J Cancer. 2015 Feb 15; 136(4):875-9.
    View in: PubMed
    Score: 0.047
  11. miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer. PLoS One. 2014; 9(6):e98675.
    View in: PubMed
    Score: 0.047
  12. ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC). PLoS One. 2013; 8(8):e72829.
    View in: PubMed
    Score: 0.044
  13. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neurooncol. 2013 Nov; 115(2):143-51.
    View in: PubMed
    Score: 0.044
  14. The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis. 2010 Sep; 13(3):208-17.
    View in: PubMed
    Score: 0.036
  15. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med. 2016 Jan 14; 374(2):135-45.
    View in: PubMed
    Score: 0.013
  16. Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer. Prostate Cancer Prostatic Dis. 2011 Dec; 14(4):279-85.
    View in: PubMed
    Score: 0.010
  17. Dicer ablation impairs prostate stem cell activity and causes prostate atrophy. Stem Cells. 2010 Jul; 28(7):1260-9.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.